A double-blind, randomized, parallel group trial of Ditropan XL (oxybutynin chloride) extended release tablets or placebo in combination with Flomax (tamsulosin hydrochloride) for the treatment of lower urinary tract symptoms

Trial Profile

A double-blind, randomized, parallel group trial of Ditropan XL (oxybutynin chloride) extended release tablets or placebo in combination with Flomax (tamsulosin hydrochloride) for the treatment of lower urinary tract symptoms

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Apr 2010

At a glance

  • Drugs Oxybutynin; Tamsulosin
  • Indications Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Sponsors McNeil Consumer Pharmaceuticals
  • Most Recent Events

    • 02 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top